Stromelysin/transin and tumor progression

Matrisian, L.M.; Bowden, G.T.

Seminars in Cancer Biology 1(2): 107-115

1990


ISSN/ISBN: 1044-579X
PMID: 2103488
Document Number: 354007
Transin is an oncogene-inducible protein which has been shown to be the rat homologue of an extracellular matrix-degrading metalloproteinase known as stromelysin. The activity of transin/stromelysin is regulated at several levels: (1) at the transcriptional level, it is positively regulated by oncogenes, tumor promoters, and certain growth factors, and is negatively regulated by several agents including glucocorticoids and transforming growth factor-beta; (2) the protease activity is produced by processing of an inactive precursor form to an active enzyme; and (3) total protease activity is modulated by activity of tissue inhibitors of metalloproteinases (TIMPs). The association of transin/stromelysin expression with tumor progression suggests that it plays an important role in cancer.

Document emailed within 1 workday
Secure & encrypted payments